Investor.ironwoodpharma.com is a subdomain of ironwoodpharma.com,
which was created on 2007-10-17,making it 17 years ago.
It has several subdomains, such as hip.ironwoodpharma.com , among others.
Discover investor.ironwoodpharma.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site
HomePage size: 103.188 KB |
Page Load Time: 0.54324 Seconds |
Website IP Address: 162.159.130.11 |
Tractor Supply Company - Company Overview |
Investor Relations :: CNS Pharmaceuticals, Inc. (CNSP) |
Mirum Pharmaceuticals, Inc. - Investor Relations |
Multilingual Psychotherapy Centers, Inc. Jobs: Overview | Multilingual Psychotherapy Centers, Inc. |
Ironwood Counseling and Psychological Services | CarePaths EHR and Measurement Based Care |
Rise Services, Inc. Jobs: Overview | Rise Services, Inc. |
Ironwood HIP |
Best Western International, Inc. Jobs: Overview | Best Western International, Inc. |
CODAC Health, Recovery & Wellness Inc. Jobs: Overview | CODAC Health, Recovery & Wellness Inc. |
Momenta Pharmaceuticals, Inc. - News/Events - Overview |
Overview | Cyclacel Pharmaceuticals, Inc. |
Investors | Fusion Pharmaceuticals - Overview |
Lifeline Pharmaceuticals, LLC’s Login Page | Lifeline Pharmaceuticals, LLC |
Ironwood Church | Non-Denominational Church in Mesa, AZ |
Neuropathix, Inc. – A Phyto-Medical Company | Developing Pharmaceuticals to Protect the Brain |
Ironwood Pharmaceuticals, Inc. - Company Overview https://investor.ironwoodpharma.com/home/default.aspx |
Press Releases https://investor.ironwoodpharma.com/press-releases/default.aspx |
Ironwood Pharmaceuticals, Inc. - Investor Contacts https://investor.ironwoodpharma.com/investor-contacts/default.aspx |
Why Invest https://investor.ironwoodpharma.com/Why-Invest/default.aspx |
Financials - Annual Reports https://investor.ironwoodpharma.com/financials/annual-reports/default.aspx |
Financials - Quarterly Results https://investor.ironwoodpharma.com/financials/quarterly-results/default.aspx |
Stock Information - Analyst Coverage https://investor.ironwoodpharma.com/stock-information/analyst/default.aspx |
Press Releases https://investor.ironwoodpharma.com/press-releases/2014/default.aspx |
Financials - SEC Filings https://investor.ironwoodpharma.com/financials/sec-filings/default.aspx |
Events & Presentations https://investor.ironwoodpharma.com/events-and-presentations/default.aspx |
Date: Tue, 14 May 2024 06:55:15 GMT |
Content-Type: text/html; charset=utf-8 |
Transfer-Encoding: chunked |
Connection: keep-alive |
CF-Ray: 8838fb467e6a5ee9-PDX |
CF-Cache-Status: REVALIDATED |
Cache-Control: public, max-age=10, stale-if-error=86400, stale-while-revalidate=86400 |
Strict-Transport-Security: max-age=31536000; includeSubDomains |
Vary: Accept-Encoding |
X-Content-Type-Options: nosniff |
X-XSS-Protection: 0 |
Server: cloudflare |
content="text/html; charset=utf-8" http-equiv="Content-type"/ |
content="RevealTrans(Duration=0,Transition=0)" http-equiv="Page-Enter"/ |
content="IE=edge,chrome=1" http-equiv="X-UA-Compatible"/ |
content="width=device-width, initial-scale=1" name="viewport"/ |
content="--OGiUxoB-WvaAIinUP__X6sU48peEYfvr4-iMaqNHA" name="google-site-verification"/ |
Investors Media open in a new window Contact Us open in a new window | Search open in a new window Company Science & Medicine Patients Responsibility Careers IR Home Why Invest Events & Presentations Corporate Governance Governance Documents Executive Management Board of Directors Committee Composition Annual Meeting Contact the Board Financials Quarterly Results Annual Reports SEC Filings Press Releases Investor Contacts Investor Emails Alerts RSS Feeds Stock Information Stock Quote & Chart Historical Stock Quote Analyst Coverage Investor FAQs IR Home Why Invest Events & Presentations Corporate Governance Governance Documents Executive Management Board of Directors Committee Composition Annual Meeting Contact the Board Financials Quarterly Results Annual Reports SEC Filings Press Releases Investor Contacts Investor Emails Alerts RSS Feeds Stock Information Stock Quote & Chart Historical Stock Quote Analyst Coverage Investor FAQs Close Close Investors Company Product Research & Development Patients Partnerships Careers Close Company Overview We Are Ironwood A GI-focused Healthcare Company A Leading GI Healthcare Company Corporate Overview Ironwood Pharmaceuticals (Nasdaq: IRWD), an S&P SmallCap 600® company, is a leading global gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients. We are pioneers in the development of LINZESS® (linaclotide), the U.S. branded prescription market leader for adults with irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC). LINZESS is also approved for the treatment of functional constipation in pediatric patients ages 6-17 years-old. Ironwood is also advancing apraglutide, a next-generation, long-acting synthetic GLP-2 analog being developed for rare gastrointestinal diseases, including short bowel syndrome with intestinal failure (SBS-IF), as well as several earlier stage assets. Building upon our history of GI innovation, we keep patients at the heart of our R&D and commercialization efforts to reduce the burden of GI diseases and address significant unmet needs. Founded in 1998, Ironwood Pharmaceuticals is headquartered in Boston, Massachusetts, with a site in Basel, Switzerland. Learn More28.5 Million Adult Americans may suffer from Chronic Idiopathic Constipation (CIC) 11.5 Million Adult Americans may have Irritable Bowl Syndrome with Constipation (IBS-C) ~5 Million Unique Patients since the launch of LINZESS Featured Reports View All Results Featured Events See All Events Recent News See All News Investor Alerts To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time. At Ironwood Pharmaceuticals, Inc., we strive to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance. By providing your email address below, you are providing consent to Ironwood Pharmaceuticals, Inc. to send you the requested Investor Email Alert updates. * Required Email Address * Mailing Lists * News Events & Presentations SEC Filings End of Day Stock Quote Quarterly Reports Annual Reports Email Alert Sign Up Confirmation open in a new window Investors Media Contact us Follow us on Linkedin Follow us on Twitter COMPANY Company Overview Leadership Open Payments & Transparecy SCIENCE & MEDICINE Therapeutic Focus Pipeline Product PatientsPATIENTS Overview RESPONSIBILITY Overview Diversity, Equity & Inclusion Sustainability Safety & Compliance Patients & Research Community Giving CAREERS Working at Ironwood Internships, Co-ops & Fellowships Open Positions Copyright © Ironwood. All rights reserved Powered By Q4 Inc. 5.77.0.2 (opens in new window) Privacy Policy California Privacy PolicySite Map Terms of...
Domain Name: IRONWOODPHARMA.COM Registry Domain ID: 1281721989_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2022-10-18T20:23:22Z Creation Date: 2007-10-17T20:40:08Z Registry Expiry Date: 2032-10-17T20:40:08Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS1.EASYDNS.COM Name Server: NS2.EASYDNS.COM Name Server: NS3.EASYDNS.ORG Name Server: NS6.EASYDNS.NET Name Server: REMOTE1.EASYDNS.COM Name Server: REMOTE2.EASYDNS.COM DNSSEC: unsigned >>> Last update of whois database: 2024-05-17T19:26:43Z <<<